miR-302 Suppresses the Proliferation, Migration, and Invasion of Breast Cancer Cells by Downregulating ATAD2.

Hwang, Yo Sep; Park, Eun Sun; Oh, Byung Moo; Uhm, Tae Gi; Yoon, Suk Ran; Park, Jong-Lyul; Cho, Hee Jun; Lee, Hee Gu

Hwang, Yo Sep; Park, Eun Sun; Oh, Byung Moo; Uhm, Tae Gi; Yoon, Suk Ran; Park, Jong-Lyul; Cho, Hee Jun; Lee, Hee Gu.

Afiliación

Hwang YS; Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology, Yuseong-gu, Daejeon 34141, Korea.
Park ES; Department of Biomolecular Science, KRIBB School of Bioscience, Korea University of Science and Technology (UST), Yuseong-gu, Daejeon 34113, Korea.
Oh BM; Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology, Yuseong-gu, Daejeon 34141, Korea.
Uhm TG; Department of Biomolecular Science, KRIBB School of Bioscience, Korea University of Science and Technology (UST), Yuseong-gu, Daejeon 34113, Korea.
Yoon SR; Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology, Yuseong-gu, Daejeon 34141, Korea.
Park JL; Department of Biomolecular Science, KRIBB School of Bioscience, Korea University of Science and Technology (UST), Yuseong-gu, Daejeon 34113, Korea.
Cho HJ; Plumbline Life Science Inc., College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Lee HG; Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology, Yuseong-gu, Daejeon 34141, Korea.

Cancers (Basel) ; 14(18)2022 Sep 06.

Article en En | MEDLINE | ID: mdl-36139505

Palabras clave

ATAD2; breast cancer; invasion; miR-302; proliferation; tumor growth

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article